<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27058763</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0341</ISSN><JournalIssue CitedMedium="Internet"><Volume>493</Volume><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Virology</Title><ISOAbbreviation>Virology</ISOAbbreviation></Journal><ArticleTitle>Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells.</ArticleTitle><Pagination><StartPage>162</StartPage><EndPage>172</EndPage><MedlinePgn>162-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2016.03.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0042-6822(16)30053-8</ELocationID><Abstract><AbstractText>Megakaryocyte-erythrocyte progenitor (MEP) cells are potential in vivo targets of dengue virus (DENV); the virus has been found associated with megakaryocytes ex vivo and platelets during DENV-induced thrombocytopenia. We report here that DENV serotype 2 (DENV2) propagates well in human nondifferentiated MEP cell lines (Meg01 and K562). In comparison to virus propagated in Vero cells, viruses from MEP cell lines had similar structure and buoyant density. However, differences in MEP-DENV2 stability and composition were suggested by distinct protein patterns in western blot analysis. Also, antibody neutralization of envelope domain I/II on MEP-DENV2 was reduced relative to that on Vero-DENV2. Infectious DENV2 was produced at comparable kinetics and magnitude in MEP and Vero cells. However, fewer virion structures appeared in electron micrographs of MEP cells. We propose that DENV2 infects and produces virus efficiently in megakaryocytes and that megakaryocyte impairment might contribute to dengue disease pathogenesis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Kristina B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Hui-Mien</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Department of Pediatrics, Emory University School of Medicine and Veterans Affairs Medical Center, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassit</LastName><ForeName>Leda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Department of Pediatrics, Emory University School of Medicine and Veterans Affairs Medical Center, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crowe</LastName><ForeName>James E</ForeName><Initials>JE</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Departments of Pediatrics, Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schinazi</LastName><ForeName>Raymond F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Department of Pediatrics, Emory University School of Medicine and Veterans Affairs Medical Center, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Guey Chuen</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villinger</LastName><ForeName>Francois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R24 OD010947</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virology</MedlineTA><NlmUniqueID>0110674</NlmUniqueID><ISSNLinking>0042-6822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055015" MajorTopicYN="N">Megakaryocyte-Erythroid Progenitor Cells</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dengue virus</Keyword><Keyword MajorTopicYN="N">Electron microscopy</Keyword><Keyword MajorTopicYN="N">Erythrocyte</Keyword><Keyword MajorTopicYN="N">K562</Keyword><Keyword MajorTopicYN="N">MEP</Keyword><Keyword MajorTopicYN="N">Meg01</Keyword><Keyword MajorTopicYN="N">Megakaryocyte</Keyword><Keyword MajorTopicYN="N">Progenitor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27058763</ArticleId><ArticleId IdType="mid">NIHMS855240</ArticleId><ArticleId IdType="pmc">PMC5538722</ArticleId><ArticleId IdType="doi">10.1016/j.virol.2016.03.024</ArticleId><ArticleId IdType="pii">S0042-6822(16)30053-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AbuBakar S, Shu MH, Johari J, Wong PF. Senescence affects endothelial cells susceptibility to dengue virus infection. Int J Med Sci. 2014;11:538&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003538</ArticleId><ArticleId IdType="pubmed">24782642</ArticleId></ArticleIdList></Reference><Reference><Citation>Ader DB, Celluzzi C, Bisbing J, Gilmore L, Gunther V, Peachman KK, Rao M, Barvir D, Sun W, Palmer DR. Modulation of dengue virus infection of dendritic cells by Aedes aegypti saliva. Viral Immunol. 2004;17:252&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">15279703</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison SL, Tao YJ, O&#x2019;Riordain G, Mandl CW, Harrison SC, Heinz FX. Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus. J Virol. 2003;77:11357&#x2013;11366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC229348</ArticleId><ArticleId IdType="pubmed">14557621</ArticleId></ArticleIdList></Reference><Reference><Citation>de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White AM, Diamond MS, Baric RS, Crowe JE, Jr, de Silva AM. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci USA. 2012;109:7439&#x2013;7444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358852</ArticleId><ArticleId IdType="pubmed">22499787</ArticleId></ArticleIdList></Reference><Reference><Citation>Arevalo MT, Simpson-Haidaris PJ, Kou Z, Schlesinger JJ, Jin X. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection. J Med Virol. 2009;81:519&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">19152413</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A, Jain P, Gangodkar SV, Shetty S, Ghosh K. Dengue 2 virus inhibits in vitro megakaryocytic colony formation and induces apoptosis in thrombopoietin-inducible megakaryocytic differentiation from cord blood CD34+cells. FEMS Immunol Med Microbiol. 2008;53:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">18371071</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NT, Sukupolvi-Petty S, Navarro-Sanchez E, Young PR, de Silva AM, Rey FA, Varani L, Whitehead SS, Diamond MS, Harris E, Lanzavecchia A, Sallusto F. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe. 2010;8:271&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884547</ArticleId><ArticleId IdType="pubmed">20833378</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierman HR, Nelson ER. Hematodepressive virus diseases of Thailand. Ann Intern Med. 1965;62:867&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">14283387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant JE, Calvert AE, Mesesan K, Crabtree MB, Volpe KE, Silengo S, Kinney RM, Huang CY, Miller BR, Roehrig JT. Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes. Virology. 2007;366:415&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">17543367</ArticleId></ArticleIdList></Reference><Reference><Citation>Butthep P, Bunyaratvej A, Bhamarapravati N. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 1993;24(1):246&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">7886587</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark KB, Noisakran S, Onlamoon N, Hsiao HM, Roback J, Villinger F, Ansari AA, Perng GC. Multiploid CD61+cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow. Plos One. 2012;7:e52902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3531377</ArticleId><ArticleId IdType="pubmed">23300812</ArticleId></ArticleIdList></Reference><Reference><Citation>Daughaday CC, Brandt WE, McCown JM, Russell PK. Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun. 1981;32:469&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC351468</ArticleId><ArticleId IdType="pubmed">7251133</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Webb AI, Chan V, Jumnainsong A, Davidson A, Mon-gkolsapaya J, Screaton G. Lectin switching during dengue virus infection. J Infect Dis. 2011;203:1775&#x2013;1783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3100511</ArticleId><ArticleId IdType="pubmed">21606536</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol. 2000;74:7814&#x2013;7823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112311</ArticleId><ArticleId IdType="pubmed">10933688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferlenghi I, Clarke M, Ruttan T, Allison SL, Schalich J, Heinz FX, Harrison SC, Rey FA, Fuller SD. Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell. 2001;7:593&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">11463384</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006;19:429&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">16940865</ArticleId></ArticleIdList></Reference><Reference><Citation>Hase T, Summers PL, Eckels KH, Baze WB. An electron and immunoelectron microscopic study of dengue-2 virus infection of cultured mosquito cells: maturation events. Arch Virol. 1987;92:273&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">3813888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, Lai JH. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol. 2001;166:1499&#x2013;1506.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160189</ArticleId></ArticleIdList></Reference><Reference><Citation>Houng HS, Chung-Ming Chen R, Vaughn DW, Kanesa-thasan N. Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1&#x2013;4 using conserved and serotype-specific 3&#x2032; noncoding sequences. J Virol Methods. 2001;95:19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">11377710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu AY, Wu SR, Tsai JJ, Chen PL, Chen YP, Chen TY, Lo YC, Ho TC, Lee M, Chen MT, Chiu YC, Perng GC. Infectious dengue vesicles derived from CD61+cells in acute patient plasma exhibited a diaphanous appearance. Sci Rep. 2015;5:17990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4675971</ArticleId><ArticleId IdType="pubmed">26657027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa T, Konishi E. Mosquito cells infected with Japanese encephalitis virus release slowly-sedimenting hemagglutinin particles in association with intracellular formation of smooth membrane structures. Microbiol Immunol. 2006;50:211&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">16547419</ArticleId></ArticleIdList></Reference><Reference><Citation>Junjhon J, Pennington JG, Edwards TJ, Perera R, Lanman J, Kuhn RJ. Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells. J Virol. 2014;88:4687&#x2013;4697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3993787</ArticleId><ArticleId IdType="pubmed">24522909</ArticleId></ArticleIdList></Reference><Reference><Citation>Junjhon J, Lausumpao M, Supasa S, Noisakran S, Songjaeng A, Saraithong P, Chaichoun K, Utaipat U, Keelapang P, Kanjanahaluethai A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N. Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction. J Virol. 2008;82:10776&#x2013;10791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2573171</ArticleId><ArticleId IdType="pubmed">18715923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho LK, Wulur H, Himawan T. Blood and bone marrow changes in dengue haemorrhagic fever. Paediatr Indones. 1972;12:31&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">5032319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko KK, Igarashi A, Fukai K. Electron microscopic observations on Aedes albopictus cells infected with dengue viruses. Arch Virol. 1979;62:41&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">539910</ArticleId></ArticleIdList></Reference><Reference><Citation>La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol. 1995;8:249&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">7663049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Leang SK, Davidson A, Lobigs M. Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release. J Virol. 2010;84:5171&#x2013;5180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2863807</ArticleId><ArticleId IdType="pubmed">20219924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, Hsieh CJ, Chen RF, Yang ZS, Wang L, Chen CM, Liu CF, Huang CH, Lin JW, Chen YH, Yang KD, Liu JW. Increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes&#x2019; mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication. Biomed Res Int. 2013;2013:965853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3773921</ArticleId><ArticleId IdType="pubmed">24078930</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol. 2001;75:3501&#x2013;3508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114841</ArticleId><ArticleId IdType="pubmed">11264339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozzio BB, Lozzio CB, Bamberger EG, Feliu AS. A multipotential leukemia cell line (K-562) of human origin. Proc Soc Exp Biol Med. 1981;166:546&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">7194480</ArticleId></ArticleIdList></Reference><Reference><Citation>Marianneau P, Steffan AM, Royer C, Drouet MT, Jaeck D, Kirn A, Deubel V. Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident. J Virol. 1999;73:5201&#x2013;5206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112571</ArticleId><ArticleId IdType="pubmed">10233989</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosquera JA, Hernandez JP, Valero N, Espina LM, Anez GJ. Ultra-structural studies on dengue virus type 2 infection of cultured human monocytes. Virol J. 2005;2:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1082913</ArticleId><ArticleId IdType="pubmed">15801983</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakao S, Lai CJ, Young NS. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood. 1989;74:1235&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">2765663</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson ER, Bierman HR, Chulajata R. Hematologic Findings in the 1960 Hemorrhagic Fever Epidemic (Dengue) in Thailand. Am J Trop Med Hyg. 1964;13:642&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pubmed">14196064</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen DG. The relationship of interacting immunological components in dengue pathogenesis. Virol J. 2009;6:211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2789730</ArticleId><ArticleId IdType="pubmed">19941667</ArticleId></ArticleIdList></Reference><Reference><Citation>Noisakran S, Onlamoon N, Hsiao HM, Clark KB, Villinger F, Ansari AA, Perng GC. Infection of bone marrow cells by dengue virus in vivo. Exp Hematol. 2012;40:250&#x2013;259. e254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3415316</ArticleId><ArticleId IdType="pubmed">22193689</ArticleId></ArticleIdList></Reference><Reference><Citation>Noisakran S, Gibbons RV, Songprakhon P, Jairungsri A, Ajariyakhajorn C, Nisalak A, Jarman RG, Malasit P, Chokephaibulkit K, Perng GC. Detection of dengue virus in platelets isolated from dengue patients. Southeast Asian J Trop Med Public Health. 2009;40:253&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">19323010</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke F. Observations on pool and capillary feeding in Aedes aegypti. Nature. 1956;177:1087&#x2013;1088.</Citation></Reference><Reference><Citation>Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood. 1985;66:1384&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">2998511</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasteur S. Sanofi Pasteur&#x2019;s dengue vaccine candidate successfully completes final landmark phase iii clinical efficacy study in Latin America. Sanofi Pasteur 2014</Citation></Reference><Reference><Citation>Pryor MJ, Azzola L, Wright PJ, Davidson AD. Histidine 39 in the dengue virus type 2 M protein has an important role in virus assembly. J Gen Virol. 2004;85:3627&#x2013;3636.</Citation><ArticleIdList><ArticleId IdType="pubmed">15557235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth NG, Lang J. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet. 2012;380:1559&#x2013;1567.</Citation><ArticleIdList><ArticleId IdType="pubmed">22975340</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha B, Brien JD, Sukupolvi-Petty S, Austin SK, Edeling MA, Kim T, O&#x2019;Brien KM, Nelson CA, Johnson S, Fremont DH, Diamond MS. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. Plos Pathog. 2010;6:e1000823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848552</ArticleId><ArticleId IdType="pubmed">20369024</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SA, Zhou Y, Olivarez NP, Broadwater AH, de Silva AM, Crowe JE., Jr Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol. 2012;86:2665&#x2013;2675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302281</ArticleId><ArticleId IdType="pubmed">22171265</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TJ, Brandt WE, Swanson JL, McCown JM, Buescher EL. Physical and biological properties of dengue-2 virus and associated antigens. J Virol. 1970;5:524&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC376035</ArticleId><ArticleId IdType="pubmed">4195055</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriurairatna S, Bhamarapravati N, Phalavadhtana O. Dengue virus infection of mice: morphology and morphogenesis of dengue type-2 virus in suckling mouse neurones. Infect Immun. 1973;8:1017&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC422964</ArticleId><ArticleId IdType="pubmed">4594115</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens TM, Schlesinger RW. Studies on the nature of dengue viruses. I. Correlation of particle density, infectivity, and RNA content of type 2 virus. Virology. 1965;27:103&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">5828097</ArticleId></ArticleIdList></Reference><Reference><Citation>Styer LM, Kent KA, Albright RG, Bennett CJ, Kramer LD, Bernard KA. Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. Plos Pathog. 2007;3:1262&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1976553</ArticleId><ArticleId IdType="pubmed">17941708</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P, Fernandez S, Marovich MA, Palmer DR, Celluzzi CM, Boonnak K, Liang Z, Subramanian H, Porter KR, Sun W, Burgess TH. Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology. 2009;383:207&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">19013627</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasaki T, Takada K, Kurane I. Electron microscopic study of persistent dengue virus infection: analysis using a cell line persistently infected with Dengue-2 virus. Intervirology. 2001;44:48&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">11223720</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan TY, Chu JJ. Dengue virus-infected human monocytes trigger late activation of caspase-1, which mediates pro-inflammatory IL-1beta secretion and pyroptosis. J Gen Virol. 2013;94:2215&#x2013;2220.</Citation><ArticleIdList><ArticleId IdType="pubmed">23884363</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilopoulos AN, Brandt WE, Russell PK, Dixon FT. Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol. 1976;117:953&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pubmed">1085314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai JJ, Liu LT, Chang K, Wang SH, Hsiao HM, Clark KB, Perng GC. The importance of hematopoietic progenitor cells in dengue. Ther Adv Hematol. 2012;3:59&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3573426</ArticleId><ArticleId IdType="pubmed">23556112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva AM. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology. 2009;392:103&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2746956</ArticleId><ArticleId IdType="pubmed">19631955</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Dengue and Severe Dengue Fact Sheet N117, Dengue and Severe Dengue. World Health Organization; Geneva, Switzerland: 2015.</Citation></Reference><Reference><Citation>Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS. Human skin Langerhans cells are targets of dengue virus infection. Nat Med. 2000;6:816&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">10888933</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii K, Konno A, Goto A, Nio J, Obara M, Ueki T, Hayasaka D, Mizutani T, Kariwa H, Takashima I. Single point mutation in tick-borne encephalitis virus prM protein induces a reduction of virus particle secretion. J Gen Virol. 2004;85:3049&#x2013;3058.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448368</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>